FDA — authorised 31 August 1995
- Application: ANDA074334
- Marketing authorisation holder: WATSON LABS
- Local brand name: VECURONIUM BROMIDE
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 Muscle relaxant therapy in United States
FDA authorised Muscle relaxant therapy on 31 August 1995
Marketing authorisations
FDA — authorised 23 August 1999
- Application: ANDA075218
- Marketing authorisation holder: HIKMA
- Local brand name: VECURONIUM BROMIDE
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA — authorised 25 August 1999
- Application: ANDA074688
- Marketing authorisation holder: MEITHEAL
- Local brand name: VECURONIUM BROMIDE
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA — authorised 21 October 1999
- Application: ANDA075164
- Marketing authorisation holder: HOSPIRA
- Local brand name: VECURONIUM BROMIDE
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA — authorised 13 June 2000
- Application: ANDA075549
- Marketing authorisation holder: HIKMA
- Local brand name: VECURONIUM BROMIDE
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA — authorised 11 September 2001
- Application: ANDA075558
- Marketing authorisation holder: HOSPIRA
- Local brand name: VECURONIUM BROMIDE
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA — authorised 29 December 2008
- Application: ANDA078274
- Marketing authorisation holder: SAGENT PHARMS INC
- Local brand name: VECURONIUM BROMIDE
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA — authorised 17 June 2009
- Application: ANDA079001
- Marketing authorisation holder: SUN PHARM
- Local brand name: VECURONIUM BROMIDE
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA — authorised 11 May 2010
- Application: ANDA090243
- Marketing authorisation holder: MYLAN LABS LTD
- Local brand name: VECURONIUM BROMIDE
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA — authorised 26 May 2016
- Application: ANDA205390
- Marketing authorisation holder: GLAND
- Local brand name: VECURONIUM BROMIDE
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA — authorised 20 December 2018
- Application: ANDA206670
- Marketing authorisation holder: EUGIA PHARMA
- Local brand name: VECURONIUM BROMIDE
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA — authorised 30 July 2019
- Application: ANDA203725
- Marketing authorisation holder: HIKMA
- Local brand name: VECURONIUM BROMIDE
- Indication: INJECTABLE — INJECTION
- Status: approved
Other Musculoskeletal/Pain Management approved in United States
Frequently asked questions
Is Muscle relaxant therapy approved in United States?
Yes. FDA authorised it on 31 August 1995; FDA authorised it on 23 August 1999; FDA authorised it on 25 August 1999.
Who is the marketing authorisation holder for Muscle relaxant therapy in United States?
WATSON LABS holds the US marketing authorisation.